Cultivation Capital

Cultivation Capital is a St. Louis-based venture capital firm with multiple sector-specific funds spanning software, agriculture and food technology, life sciences, and geospatial. The firm has been one of the most active early-stage investors in the central U.S., with a particular concentration in the Midwest and a mature life sciences practice that has backed therapeutics, diagnostics, and digital health companies, often co-investing with coastal specialist funds. For healthcare AI founders, Cultivation Capital’s life sciences fund is the relevant entry point, with typical check sizes ranging from $250K to $2M at seed and Series A, with reserves for follow-on. The strongest fit is for healthcare AI companies headquartered in or substantially operating across the Midwest, particularly those connected to St. Louis healthcare and academic anchors like Washington University, BJC HealthCare, or BioSTL. Founders building AI for diagnostics, drug discovery, clinical decision support, agriculture-health convergence, or digital therapeutics with credible clinical evidence pathways will find the firm thesis-relevant. Coastal founders without Midwest operating presence are less likely to convert, and consumer health or pure consumer wellness plays are not the firm’s lane. Cultivation’s value-add is most credible around regional customer development, life sciences scientific advisory networks, and bridging founders to coastal follow-on capital. Entry path is through the website, LinkedIn outreach to the relevant fund partners, or warm referral from BioSTL or a Cultivation portfolio CEO. Founders should come ready to discuss clinical evidence, regulatory pathway, and a defensible technical or scientific moat, alongside standard commercial metrics.